CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Autor principal: | Eva, Israt Ara Jannat |
|---|---|
| Outros Autores: | Rahman, Kazi Fatema |
| Formato: | Tese |
| Idioma: | English |
| Publicado em: |
Brac University
2023
|
| Assuntos: | |
| Acesso em linha: | http://hdl.handle.net/10361/17764 |
Registros relacionados
-
A review on CRISPR-Cas system based applications in Oncology
por: Sadia, Mir
Publicado em: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
por: Maria, Amatul
Publicado em: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
por: Nwabunwanne, Eze Uchenna
Publicado em: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
por: Shaikat, Mahdi Mubin
Publicado em: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
por: Ullah, Mohammad
Publicado em: (2023)